Why Dye & Durham Stock Plunged 16% Last Week

DND stock looks attractive for long-term investors after it has fallen by 60% in 2022 so far.

| More on:

What happened?

Shares of Dye & Durham (TSX: DND) tanked by about 16% to $17.97 per share last week to post its biggest weekly losses since the first week of May. With this, DND stock underperformed the broader market by a wide margin, as the TSX Composite Index ended the week with a 3.3% decline. The latest round of heavy selling in the stock has extended its year-to-date losses to a massive 60%.

So what?

Last week’s sharp selloff in Dye & Durham stock came after a Bloomberg report claimed that the Canadian software company is considering walking away from the Link Administration Holdings acquisition deal, citing people familiar with the matter. Link Group is a Sydney-based software firm that primarily provides record-keeping technology and information solutions to the superannuation administration industry. The Australian Securities Exchange-listed Link Group currently has a market cap of about AU$2 billion.

Dye & Durham originally announced the agreement to acquire Link Group in December last year in a deal worth $3.2 billion, reflecting a 15% premium over Link’s then share price. However, Link’s shares have seen nearly 17% value erosion since then. Following this, Dye & Durham reduced its proposal from a cash consideration of AU$5.50 per Link’s share to AU$4.30 per share in June.

The Canadian software company expected this acquisition to help it expand its global footprint and customer base in business-to-business software and information service solutions segments. That’s why investors might be reacting negatively to the possibility of it walking away from the deal, triggering a selloff in DND stock.

Now what?

While the speculations about Dye & Durham walking away from the Link Group acquisition deal might keep its stock volatile in the near term, I still find really attractive for long-term investors — especially when it’s down 60% year to date. In its fiscal year 2022 (ended in June), analysts expect its total sales to more than double on a year-over-year basis to around $482 million with the help of consistently growing demand for its cloud-based software solutions. Given that, investors may want to take advantage of the recent selloff in DND stock to buy this amazing growth stock at a big bargain.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

More on Tech Stocks

space ship model takes off
Dividend Stocks

2 Stocks I’d Avoid in 2025 (and 1 I’d Buy)

Two low-priced stocks are best avoided for now but a surging oil bellwether is a must-buy.

Read more »

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

ways to boost income
Tech Stocks

2 Stocks to Help Turn $100,000 Into $1 Million

Do you want to turn $100,000 into $1 million quickly? Look for small- or mid-cap stocks that are scaling as…

Read more »

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »